This study is for asthmatics who continue to have asthma symptoms despite daily treatment with medications such as inhaled corticosteroids (e.g., Flovent) or inhaled corticosteroids with long-acting beta agonists and/or long-acting muscarinic antagonists (e.g., Advair). Participants cannot be on Prednisone for six weeks before the trial begins.
The purpose of the study is to see if a new investigational medication can control inflammation, mucous production and swelling in the lungs, as well as difficulty breathing in people with steroid-resistant asthma.
Study participation involves:
- 2 visits over 7-8 days
- Blood draw
- Spirometry at no cost to you
- Study medication at no cost to you